# Summit Therapeutics Inc. (SMMT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Summit Therapeutics Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/SMMT/mda/fy2025/): filed 2026-02-23; accession 0001599298-26-000015 (https://www.sec.gov/Archives/edgar/data/1599298/000159929826000015/smmt-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/SMMT/mda/fy2024/): filed 2025-02-24; accession 0001599298-25-000048 (https://www.sec.gov/Archives/edgar/data/1599298/000159929825000048/smmt-20241231.htm)
- [FY 2023 MD&A](/company/SMMT/mda/fy2023/): filed 2024-02-20; accession 0001599298-24-000031 (https://www.sec.gov/Archives/edgar/data/1599298/000159929824000031/smmt-20231231.htm)
- [FY 2022 MD&A](/company/SMMT/mda/fy2022/): filed 2023-03-09; accession 0001599298-23-000034 (https://www.sec.gov/Archives/edgar/data/1599298/000159929823000034/smmt-20221231.htm)
- [FY 2021 MD&A](/company/SMMT/mda/fy2021/): filed 2022-03-17; accession 0001599298-22-000032 (https://www.sec.gov/Archives/edgar/data/1599298/000159929822000032/smmt-20211231.htm)

Back to /company/SMMT/